This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their article, Meier et al¹ did not find any statistically significant differences in mortality between the group of patients diagnosed using the older World Health Organization criteria for acute myocardial infarction that relies on history, creatine kinase enzyme level, and/or electrocardiographic changes and the group diagnosed using the newer European Society of Cardiology and the American College of Cardiology criteria that incorporates troponins. However, they did find statistically significant differences in the treatment of these 2 groups of patients, with the former group receiving more aggressive in-hospital management that included the use of transcatheter interventions, heparin, and glycoprotein IIb-IIIa inhibitors. Another strategy that has emerged as important in the management of acute myocardial infarction, which was missing in the analysis by Meier et al, is the use of statin drugs. Four observational studies^2-5 and 2 randomized trials^6-7 have suggested that such a strategy not only improves outcome,^2-7 but starting . . . [Full Text of this Article]

RELATED ARTICLES

The New Definition of Myocardial Infarction
Mark A. Meier, Dean E. Smith, Kim A. Eagle, and Rajendra H. Mehta
Arch Intern Med. 2003;163(2):246.
EXTRACT | FULL TEXT  

The New Definition of Myocardial Infarction: Diagnostic and Prognostic Implications in Patients With Acute Coronary Syndromes
Mark A. Meier, Wisam H. Al-Badr, Jeanna V. Cooper, Eva M. Kline-Rogers, Dean E. Smith, Kim A. Eagle, and Rajendra H. Mehta
Arch Intern Med. 2002;162(14):1585-1589.
ABSTRACT | FULL TEXT